Price T Rowe Associates Inc. MD Has $578,000 Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Price T Rowe Associates Inc. MD lifted its stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Free Report) by 5.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 170,482 shares of the company’s stock after purchasing an additional 9,506 shares during the quarter. Price […]
